Appello Pharmaceuticals

About:

Appello Pharmaceuticals is a preclinical-stage company focused on CNS disorders.

Top Investors: Deerfield, Mountain Group Capital, Deerfield Capital Management

Description:

Appello Pharmaceuticals is a Nashville, TN based preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease.

Total Funding Amount:

$29M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Nashville, Tennessee, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)appellopharma.com

Founders:

Brian Laden

Number of Employees:

1-10

Last Funding Date:

2022-01-24

IPO Status:

Private

Industries: